Weight Loss

Weight Loss

$49 per visit, no subscription needed. Select FDA-approved GLP-1s start at $149/mo. Check your eligibility today.

Introduction to GLP-1s for weight loss

  • Walgreens Weight Management offers a variety of glucagon-like peptide-1 (GLP-1) agonist medications. A doctor or nurse practitioner will assess whether a GLP-1 agonist medication is suitable for you, taking into account your individual health factors such as BMI and medical history, and will recommend the most appropriate medication for your needs. Walgreens Weight Management offers GLP-1 agonist medications such as semaglutide (Wegovy® – oral pills & injectable pens), tirzepatide (Zepbound® – injectable KwikPens & vials), orforglipron (Foundayo™ pills), and liraglutide (Saxenda).

    Wegovy, Zepbound, Foundayo, and Saxenda medication are all FDA approved for weight loss in certain patients, but contain different active ingredients.

    • Wegovy is available as a daily oral pill and weekly injection with semaglutide as the active ingredient
    • Zepbound medication is a weekly injection with active ingredient tirzepatide
    • Foundayo medication is a daily oral pill with active ingredient orforglipron
    • Saxenda is a daily injection with active ingredient liraglutide

    All of these medications belong to the GLP-1 agonist drug class. However, Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, representing a newer generation of this therapeutic class.

  • Wegovy Opens in a new tab and Zepbound Opens in a new tab medication are both FDA-approved for weight loss and maintaining weight loss long term. Wegovy contains the active ingredient semaglutide, while Zepbound medication contains tirzepatide. Both medications:

    • Belong to the GLP-1 agonist drug class, but Zepbound medication (tirzepatide) also works as a GIP agonist, which further helps control blood sugar and improves fat storage and metabolism.
    • Are available as an injection. Wegovy is also now available as a daily pill.
    • Are approved for use in adults aged 18 years and older. Although, Wegovy can also be used in adolescents as young as 12 years of age
    Both Wegovy and Zepbound medication carry additional indications beyond weight loss.
    • Wegovy is approved to lower the risk of major adverse cardiovascular events (MACE). Injectable Wegovy is also approved for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to severe liver fibrosis.
    • Zepbound medication is approved to treat moderate to severe obstructive sleep apnea in adults with obesity.

    The right choice for you depends on your health needs. A Walgreens Weight Management provider can help determine which medication is best for you.

  • Adults aged 18 years and older with certain body mass indexes (BMI) may be eligible for a GLP-1 agonist medication (typically a BMI of 30 or above, or a BMI of 27 or above if you have a weight-related health condition such as hypertension, high cholesterol, weight-related anxiety, liver disease, sleep apnea or PCOS). You can explore options with Walgreens Weight Management. Individuals under 18 may be eligible for certain treatment options but need to talk with their health care provider.

  • Virtual care makes it easy to get support on your weight loss journey, without the hassle of scheduling appointments, going into a doctor’s office, or a subscription. With a Walgreens Weight Management visit, you’ll meet with a doctor or nurse practitioner through video shortly after you request your first visit. Our providers will review your medical history, discuss your goals, and create a personalized treatment plan. Your care plan may include a prescription for a weight loss medication, if appropriate, along with monthly follow-up connects with a provider for your first few months to check your progress and adjust your treatment as needed.

Explore more ways we can help

Frequently Asked Questions

GLP-1s

  • Glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone in your body that plays a key role in regulating blood sugar, appetite, and digestion. Medications called GLP-1 receptor agonists (also known as GLP-1 medications or GLP-1 agonists) are designed to mimic this hormone, helping to manage insulin and blood sugar levels, which can result in weight loss and blood sugar regulation.

    Some of the ways they work include reducing the feeling of hunger, making you feel fuller longer, and reducing your blood sugar. Some common examples of GLP-1 agonist medications include semaglutide (Wegovy), tirzepatide (Zepbound), orforglipron (Foundayo), and liraglutide (Saxenda).

  • GLP-1 agonist medications can help manage hunger and blood sugar in several ways, including signaling to the brain to help you feel full sooner, slowing down how quickly food leaves your stomach, helping the pancreas release insulin after meals, and reducing the release of glucagon – a hormone that raises blood sugar. These medications are often prescribed alongside lifestyle changes like diet and exercise, especially for people with obesity or prediabetes who haven’t had success with weight loss on their own.

    The average weight loss with GLP-1 medications can differ based on the specific product and the individual. In certain clinical trials, when compared to a placebo, patients who used Wegovy lost about 15% of their starting body weight in the first 1 to 1.5 years, Zepbound medication users lost 16%, Foundayo medication users lost 12.4%, and Saxenda users lost 5%. Start a Walgreens Weight Management visit to see which GLP-1 agonist may be the right fit for you.

Virtual Care

  • During your Walgreens Weight Management visit, you will fill out a questionnaire to assess whether you meet specific eligibility requirements for a consultation, which include body mass index (BMI) and any weight-related health conditions. After confirming your eligibility, your healthcare provider will work with you to create a personalized treatment plan.

  • It’s simple! After completing a short online questionnaire about your health history, if qualified, you’ll start an on-demand video visit with a Walgreens Weight Management provider. They will review your information and if appropriate, will create your treatment plan and prescribe weight loss medication. After your first visit, most follow-up visits will be conducted through chat, where your provider will check your progress and adjust your treatment plan as needed. If you ever need real-time support, like help with side effects, you can always request another on-demand video visit. We’re here to help you every step of the way!

  • Before your first visit, you’ll complete a short online questionnaire about your health history so we can make sure treatment is safe and right for you. No lab work is needed for your first visit/initial prescription. However, in order to qualify for additional refills, you’ll need to get an HbA1c test and either a basic or comprehensive metabolic panel blood test. These blood tests help track the safety and effectiveness of the treatment. If you have had these lab tests performed within the last 12 months, you can upload them to us for review. If you don’t have recent lab results, your Walgreens Weight Management provider can order them for you during your first visit.

Insurance and pricing

  • Walgreens Weight Management is designed to be a more affordable, flexible option – no insurance or subscription required. Initial video visits start at $49, follow-up chat visits and additional video visits (if needed) are $49 each. Note: The cost of the medication is separate from cost of the clinician visit. Get treatment with a GLP-1 medication for as low as $149/month with a manufacturer savings card.

    • Through August 31, 2026, pay $149/month for the two lowest doses of Wegovy Opens in a new tab pills through a Novo Nordisk offer, subsequent doses are up to $299/month, restrictions and exclusions apply.**
    • Through June 30, 2026, get first two months of Wegovy Opens in a new tab injectables for $199/month through an introductory Novo Nordisk offer, subsequent doses up to $349/month, restrictions and exclusions apply.†
    • Through December 31, 2026, get Foundayo Opens in a new tab pills starting at $149/month through a Lilly offer, subsequent doses range from $199 to $299 per month, restrictions and exclusions apply.§
    • Through December 31, 2026, get Zepbound Opens in a new tab KwikPens Lilly offer, subsequent doses range from $399 - $449 per month, restrictions and exclusions apply.‡

  • Walgreens Weight Management is currently intended for patients paying out of pocket for weight loss medications — no insurance or prior authorizations needed. We don’t currently handle insurance or prior authorizations for GLP-1s, but please check back soon. A recent survey found that only 19% of large employer plans and other firms (with 200 or more workers) offering health benefits included GLP-1 coverage for weight loss in 2025.

    Get started with GLP-1 medications for as little as $149/month. For more details about self-pay pricing with a manufacturer savings card, please see “How much does this treatment cost?” FAQ above.

  • Semaglutide (Wegovy), tirzepatide (Zepbound), orforglipron (Foundayo), liraglutide (Saxenda)1-4

    • Contraindications:
      • Personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
      • Known serious hypersensitivity to any of the ingredients in the product
    • Warnings and Precautions:
      • Thyroid C-cell tumors have occurred in animal studies; human relevance of this finding has not been determined. Report symptoms of thyroid tumors (e.g., a lump in the neck, hoarseness, dysphagia, or dyspnea) to your healthcare provider.
      • Inflammation of the pancreas (pancreatitis): contact your healthcare provider immediately if you have severe pain in your abdomen that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back.
      • Acute gallbladder disease or problems including gallstones have occurred. Call your healthcare provider if you have any of the following symptoms of gallbladder disease or complications: pain in your upper stomach (abdomen), yellowing of skin or eyes (jaundice), fever, or clay-colored stool.
      • Hypoglycemia (low blood sugar) risk is increased when using a GLP-1 agonist, especially if also taking medications such as insulin or sulfonylureas. Symptoms of low blood sugar may include dizziness or light-headedness, sweating, shakiness, blurred vision, slurred speech, weakness, anxiety, hunger, headache, irritability or mood changes, confusion or drowsiness, fast heartbeat, feeling jittery.
      • Acute kidney injury: diarrhea, nausea, and vomiting may lead to dehydration which may cause kidney problems such as acute kidney injury and, in rare cases, requiring hemodialysis. It is important that you drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.
      • Gastrointestinal adverse reactions, sometimes severe, have been reported. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
      • Hypersensitivity reactions: stop using the GLP-1 agonist and get medical help right away if you have any symptoms of a serious allergic reaction including swelling of your face, lips, tongue or throat, severe rash or itching, very rapid heartbeat, problems breathing or swallowing, fainting or feeling dizzy.
      • Increased heart rate may occur, even when at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest, lasting for several minutes.
      • Increased risk of pulmonary aspiration (food getting into your lungs) during surgery or other procedures that use anesthesia or deep sedation due to delayed gastric emptying. Tell all your healthcare providers that you are taking this GLP-1 agonist before you are scheduled to have surgery or other procedures.
      • Changes in vision. Tell your healthcare provider if you have changes in vision. A temporary worsening of diabetic retinopathy could occur. (Wegovy, Zepbound, or Foundayo only)
      • Pregnancy and breastfeeding - speak with your provider if you are or plan to be pregnant or breastfeeding, as these GLP-1 agonists should only be used during pregnancy or breastfeeding if the potential benefit outweighs potential risk to the fetus or breastfed infant.
      • Do not share your medication pen or needles with anyone else. You may give an infection to them or get an infection from them.
    • Common Side Effects
      • Wegovy: nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, belching, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis.
      • Foundayo: nausea, constipation, diarrhea, vomiting, indigestion, stomach (abdominal) pain, headache, swollen belly, feeling tired, belching, heartburn, gas, hair loss.
      • Zepbound: nausea, diarrhea, vomiting, constipation, abdominal pain, upset stomach, injection site reactions, fatigue, hypersensitivity reactions, belching, hair loss, gastroesophageal reflux disease (GERD).
      • Saxenda: nausea, diarrhea, constipation, vomiting, injection site reactions, headache, low blood sugar, upset stomach, fatigue, dizziness, abdominal pain, increased lipase (a digestive enzyme), upper abdominal pain, fever, and gastroenteritis (inflammation of the stomach and intestines).
    • Drug or Food Interactions
      • Delayed gastric emptying may impact absorption of concomitantly administered oral medications.
      • Use of GLP-1 medications may reduce the efficacy of oral hormonal contraceptives (birth control). If you are using oral hormonal contraceptives, add a non-oral contraceptive method or a barrier method of contraception for 4 weeks after starting medication and for 4 weeks after each dose increase.
      • Be sure to tell your healthcare provider about all the medications you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements. GLP-1 agonist medications can change how some medicines work, and other medicines may affect how GLP-1 medications work too.
      • Foundayo only: Do not exceed simvastatin 20 mg once daily when used concomitantly with Foundayo.

References

Disclaimers

*Currently available in the following states: AZ, CA, CO, CT, FL, GA, IL, IN, KS, KY, MA, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OK, PA, SC, TN, TX, VA, WA, WI. Chat or video visit, varies by state.

Based on national averages. Actual times may vary.

Labcorp and Quest staff are not associates, employees and/or agents of Walgreen Co. or any Walgreens subsidiary or affiliated company. Lab service will be a separate fee, price may vary.

Prescription based on medical evaluation and not guaranteed.

Walgreens-affiliated medical practices are independently owned and operated by licensed physicians who provide services using the Walgreens virtual care program telehealth platform. For more information about the relationship between Walgreens and the medical practices click here.

Walgreens Health Medical Group California P.C. is a California professional medical corporation utilizing the fictitious name "Walgreens Health Medical Group California P.C." pursuant to Cal. Bus. & Prof. Code § 2415. To view the Fictitious Name Permit click here.

This content references third-party trademarks that are the property of their respective owners. Such references are made for informational purposes only and are not sponsored, authorized, or endorsed by, or otherwise affiliated with, the respective trademark owners.

Please note that a GLP-1 medication may not be appropriate in all patients.

** Through August 31, 2026, Novo Nordisk is offering Wegovy oral medication to eligible self-pay patients for $149 per month for the 1.5 mg and 4 mg doses. After April 15, 2026, the 4 mg dose will be $199 per month. The cost of the 9 mg and 25 mg doses is $299 per month. Patients covered by government insurance programs, such as Medicare and Medicaid, are not eligible for this offer. Novo Nordisk reserves the right to modify or cancel this savings program at any time.

† Through June 30, 2026, Novo Nordisk is offering eligible self-pay patients new to Wegovy injectables an introductory price of $199 per fill for the first two fills of medication (0.25 mg and 0.5 mg doses only). After the first two fills, the cost of Wegovy will be $349 per month for subsequent fills of medication. Each fill equals a 28-day supply, which is equivalent to one month of medication. Patients covered by government insurance programs, such as Medicare and Medicaid, are not eligible for this offer. Novo Nordisk reserves the right to modify or cancel this savings program at any time.

‡ Through December 31, 2026, Lilly is offering eligible self-pay patients a 1-month supply of Zepbound 7.5 mg, 10 mg, 12.5 mg, and 15 mg dose KwikPens (or vials) for $449 each. The 1-month supply is defined as 28 days and 1 KwikPen (or 4 single-dose vials). New and existing patients will automatically receive the $449 offer on their first purchase of the 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses. To continue to be eligible for this offer, patients must refill their prescription within 45 days of prior delivery for automatic savings.

Regular price for 1-month supplies of the Zepbound KwikPen (or vial) is $299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg, $699 for 10 mg, $699 for 12.5 mg, and $699 for 15 mg. Lilly reserves the right to modify or cancel this savings program at any time.

§ Terms and Conditions for the Foundayo Self-Pay Savings Card Program
By enrolling in and using the Foundayo Self-Pay Savings Card Program (“Program”) and using the Foundayo Self-Pay Savings Card (“Card”), you attest that you meet the eligibility criteria, and you agree to comply with the terms and conditions described below:

Card Eligibility
(1.) You have been prescribed Foundayo™ (orforglipron) for an approved use consistent with FDA approved product labeling;
(2.) You agree that the Card is for self-paying (cash) patients only and that you will not seek or accept reimbursement for any out-of-pocket costs for Foundayo purchased with the Card from any third-party payer, including private insurance or state or federal healthcare programs, nor apply those costs toward any deductible or true out-of-pocket requirements;
(3.) You are a resident of the United States or Puerto Rico; and
(4.) You are 18 years of age or older.

Card Terms and Conditions
You must have a prescription for an approved use consistent with FDA-approved product labeling to: (1) Pay as low as $149 for your 1-month prescription fill of Foundayo 0.8 mg, subject to a maximum monthly savings of up to $520; (2) Pay as low as $199 for your 1-month prescription fill of Foundayo 2.5 mg, subject to a maximum monthly savings of up to $470; or (3) Pay as low as $299 for your 1-month prescription fill of Foundayo 5.5 mg, 9 mg, 14.5 mg, or 17.2 mg, subject to a maximum monthly savings of up to $370. Savings on Foundayo 14.5 mg and 17.2 mg are subject to Purchase Offer Terms and Conditions. For all Foundayo dosages, month is defined as 30-days. Card may be used for a maximum of up to 10 prescription fills per calendar year. Subject to Lilly USA, LLC’s (“Lilly”) right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason. Card expires and savings end on 12/31/2026.

Purchase Offer Terms and Conditions
You will automatically receive the $299 purchase offer on your first purchase of the 14.5 mg or 17.2 mg Foundayo dosages. To continue to be eligible for this purchase offer, you must complete your refill purchase of Foundayo within 45 days of the delivery/received date of your previous Foundayo prescription fill. Offer valid for 14.5 mg and 17.2 mg dosages of Foundayo only. New and existing patients are eligible. If refill purchase is completed more than 45 days after the delivery/receipt of your previous Foundayo prescription, purchase offer will not apply.

Regular price for a 1-month supply of Foundayo is $149 for 0.8 mg, $199 for 2.5 mg, $299 for 5.5 mg and 9 mg, and $349 for 14.5 mg and 17.2 mg. For all Foundayo dosages, 1-month supply is defined as 30-days. Additional taxes and fees may apply. This purchase offer may be terminated, rescinded, revoked, or amended by Lilly at any time, with or without notice, for any reason. Eligibility required and restrictions apply.